Tolerance/NN
to/TO
lipopolysaccharide/NN
involves/VBZ
mobilization/NN
of/IN
nuclear/JJ
factor/NN
kappa/NN
B/NN
with/IN
predominance/NN
of/IN
p50/NN
homodimers/NNS
./.

Stimulation/NN
of/IN
the/DT
human/JJ
monocytic/JJ
cell/NN
line/NN
Mono/NN
Mac/NN
6/CD
with/IN
lipopolysaccharide/NN
(/(
LPS/NN
)/)
leads/VBZ
to/TO
rapid/JJ
and/CC
transient/JJ
expression/NN
of/IN
cytokines/NNS
like/IN
tumor/NN
necrosis/NN
factor/NN
(/(
TNF/NN
)/)
./.
=====
When/WRB
such/JJ
cells/NNS
are/VBP
precultured/VBN
for/IN
2/CD
days/NNS
with/IN
a/DT
low/JJ
dose/NN
of/IN
LPS/NN
(/(
20/CD
ng/ml/NN
)/)
followed/VBN
by/IN
stimulation/NN
with/IN
a/DT
high/JJ
dose/NN
of/IN
LPS/NN
(/(
1/CD
microgram/ml/NN
)/)
,/,
expression/NN
of/IN
the/DT
TNF/NN
gene/NN
is/VBZ
minimal/JJ
,/,
i.e./FW
the/DT
cells/NNS
are/VBP
tolerant/JJ
./.
=====
In/IN
nuclear/JJ
run-on/JJ
analysis/NN
,/,
such/JJ
tolerant/JJ
cells/NNS
show/VBP
only/RB
a/DT
low/JJ
degree/NN
of/IN
transcription/NN
,/,
indicating/VBG
that/IN
tolerance/NN
operates/VBZ
at/IN
or/CC
upstream/RB
of/IN
the/DT
transcription/NN
level/NN
./.
=====
The/DT
CD14/NN
LPS/NN
receptor/NN
is/VBZ
,/,
however/RB
,/,
up-regulated/VBN
(/(
not/RB
down-regulated/VBN
)/)
in/IN
tolerant/JJ
cells/NNS
,/,
and/CC
LPS/NN
can/MD
,/,
in/IN
fact/NN
,/,
still/RB
lead/VB
to/TO
activation/NN
of/IN
tolerant/JJ
cells/NNS
as/IN
evidenced/VBN
by/IN
mobilization/NN
of/IN
the/DT
transcription/NN
factor/NN
nuclear/JJ
factor/NN
kappa/NN
B/NN
(/(
NF-kappa/NN
B/NN
)/)
./.
=====
Resolution/NN
of/IN
the/DT
NF-kappa/NN
B/NN
complex/NN
in/IN
gel/NN
shift/NN
analysis/NN
shows/VBZ
that/IN
the/DT
binding/VBG
protein/NN
,/,
mobilized/VBN
in/IN
naive/JJ
Mono/NN
Mac/NN
6/CD
cells/NNS
,/,
consists/VBZ
mainly/RB
of/IN
p50-p65/NN
heterodimers/NNS
,/,
while/IN
in/IN
tolerant/JJ
cells/NNS
,/,
the/DT
p50/NN
homodimer/NN
is/VBZ
predominant/JJ
./.
=====
This/DT
increase/NN
in/IN
p50/NN
homodimers/NNS
coincides/VBZ
with/IN
an/DT
increase/NN
in/IN
p105/NN
mRNA/NN
,/,
suggestive/JJ
of/IN
a/DT
transcriptional/JJ
up-regulation/NN
of/IN
p50/NN
./.
=====
Reporter/NN
gene/NN
analysis/NN
reveals/VBZ
that/IN
the/DT
NF-kappa/NN
B/NN
complex/NN
mobilized/VBN
in/IN
tolerant/JJ
cells/NNS
is/VBZ
functionally/RB
inactive/JJ
in/IN
that/IN
NF-kappa/NN
B-dependent/JJ
luciferase/NN
constructs/NNS
containing/VBG
the/DT
human/JJ
immunodeficiency/NN
virus/NN
long/JJ
terminal/JJ
repeat/NN
or/CC
the/DT
TNF/NN
5'-region/NN
show/VBP
only/RB
minimal/JJ
transactivation/NN
after/IN
LPS/NN
stimulation/NN
./.
=====
Similar/JJ
to/TO
Mono/NN
Mac/NN
6/CD
cells/NNS
,/,
primary/JJ
blood/NN
monocytes/NNS
,/,
when/WRB
precultured/VBN
with/IN
a/DT
low/JJ
dose/NN
of/IN
LPS/NN
,/,
also/RB
become/VBP
tolerant/JJ
and/CC
produce/VBP
little/JJ
TNF/NN
after/IN
LPS/NN
stimulation/NN
./.
=====
The/DT
tolerant/JJ
blood/NN
monocytes/NNS
also/RB
up-regulate/VBP
CD14/NN
,/,
and/CC
they/PRP
mobilize/VBP
NF-kappa/NN
B/NN
with/IN
a/DT
predominance/NN
of/IN
p50/NN
homodimers/NNS
./.
=====
Taken/VBN
together/RB
,/,
these/DT
results/NNS
demonstrate/VBP
that/IN
tolerance/NN
to/TO
LPS/NN
is/VBZ
determined/VBN
by/IN
post-receptor/JJ
mechanisms/NNS
that/WDT
involve/VBP
an/DT
altered/JJ
composition/NN
of/IN
the/DT
NF-kappa/NN
B/NN
complex/NN
./.